Stabilization and improvement seen in multiple key biopharma R&D metrics, says IQVIA ...

Retrieved on: 2025-04-15 18:22:24

Tags for this article:

Click the tags to see associated articles and topics

Stabilization and improvement seen in multiple key biopharma R&D metrics, says IQVIA .... View article details on hiswai:

Summary

The article discusses post-COVID biopharmaceutical R&D trends, highlighting IQVIA's role in clinical trials leveraging AI and cybernetics. It shows increased funding, stable trial activities, and productivity enhancements amid geopolitical and technological changes.

Article found on: www.silicon.co.uk

View Original Article